Pablo Chico-Sanchez

Profesor Asociado

Universidad Miguel Hernández de Elche Facultad de Medicina

Spain

Research Interests

Explore related searches

Professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Pablo Chico-Sanchez is an Associate Professor at Universidad Miguel Hernández de Elche Facultad de Medicina in Spain. His research focuses on the psychological aspects of illness coping, the effectiveness of mRNA vaccines, and the implications of COVID-19 on healthcare practices. Recent studies include evaluations of vaccination coverage, treatment pathways for SARS-CoV-2, and cost estimations for patients with ventilator-associated pneumonia.

Articles (15)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Pablo Chico-Sanchez

Research Interests

Explore related searches

Contact this professor

About

Articles (15)

Valproic acid could help in the fight against COVID-19: A case–control study

Differences in Psychological Coping with Illness During the Treatment and Survivorship Phases in Adolescents According to Age and Sex

Effectiveness of mRNA booster doses in preventing infections and hospitalizations due to SARS-CoV-2 and its dominant variant over time in Valencian healthcare workers, Spain

Impact of the COVID-19 Pandemic on Influenza Vaccination Coverage of Healthcare Personnel in Alicante, Spain

Mild SARS-CoV-2 infection in vulnerable patients: implementation of a clinical pathway for early treatment

Estimation of Additional Costs in Patients with Ventilator-Associated Pneumonia

Infección leve por SARS-CoV-2 en pacientes vulnerables: implantación de una vía clínica de tratamiento precoz

The Waning of BNT162b2 Vaccine Effectiveness for SARS-CoV-2 Infection Prevention over Time: A Test-Negative Study in Health Care Professionals of a Health Department from January 2021 to December 2021

The effectiveness of mRNA vaccines to prevent SARS-CoV-2 infection and hospitalisation for COVID-19 according to the time elapsed since their administration in health professionals in the Valencian Autonomous Community (Spain)

Hospitalized patients with breakthrough COVID-19: Clinical features and poor outcome predictors

Coronavirus Disease Transmission Prevented in an Endoscopy Unit with Universal Protective Measures and No Systematic Preprocedural Testing

Valproic acid could help in the fight against COVID-19: A case–control study

Estimated Costs Associated with Surgical Site Infections in Patients Undergoing Cholecystectomy

Latin American Origin Is Not Associated with Worse Outcomes among Hospitalized Patients with COVID-19 in a Public Healthcare System

Effectiveness of a SARS-CoV-2 infection-prevention model in elective surgery patients, a prospective study: Does Universal Screening Make Sense?.

Collaborators (7)

Juan Manuel Ortigosa Quiles

Celia Villodre

Patricio Más-Serrano

JUAN CARLOS RODRIGUEZ DIAZ

Esperanza Merino de Lucas

Vicente Boix

Elena Ronda

Make your next move.